The Peruvian government declares a national health emergency due to a rise of a rare autoimmune disease. The Guillain-Barré syndrome (GBS) is a known side effect of some vaccines, including the COVID-19 shots. Peru is one of the highest vaccinated countries in the world against COVID. So what are they doing about GBS? And what…
Rare Disease Erupts in Peru; WHO to Authenticate Health Records; Surprising Habits That Damage Liver
Guillain-Barré Syndrome Linked to COVID-19 Vaccine: CDC Study
A disruptive syndrome may be caused by one of the COVID-19 vaccines available in the United States, U.S. officials said in a new study. Seventy-three cases of Guillain-Barré Syndrome, which causes the immune system to attack parts of the nervous system, were confirmed in adults within 42 days of vaccination with Johnson & Johnson’s shot, the U.S. Centers…
COVID Vax Compensation Recipient ‘Disheartened’ Over Lack of Recognition of the Vaccine Injured
Ross Wightman, who was diagnosed with Guillain-Barré syndrome shortly after receiving a dose of the AstraZeneca COVID-19 vaccine, has become one of the first recipients of funds under Canada’s Vaccine Injury Support Program. But the plight of others who have suffered vaccine injuries weighs heavily on the realtor and former pilot from B.C.’s Okanagan Valley….
‘Significant’ Cases of Neurological Disorder Associated with the AstraZeneca Vaccine
A UK study by University College London has confirmed “small but significant” cases of the serious Guillain-Barre syndrome (GBS), a rare neurological disorder associated with the AstraZeneca vaccine for COVID-19. The researchers speculate that the “the majority or all” of the 121 UK cases of GBS (pdf) in March to April 2021 were associated with first…
Rare Nerve Disorder Listed as COVID-19 Vaccine Side Effect by EU
The European Union’s drug regulator listed a rare nerve disorder known as Guillain-Barré syndrome (GBS) as a possible AstraZeneca COVID-19 vaccine side effect, according to the watchdog in a Wednesday update. The European Medicines Agency (EMA) said the AstraZeneca shot, known as Vaxzevria, was associated with 833 GBS cases as of July 31. That’s out of 592 million…
Benefits of Johnson & Johnson COVID-19 Vaccine ‘Continue to Outweigh’ the Risk of Neurological Disorder: CDC Advisory Panel
The vaccine advisory panel to the Centers for Disease Control and Prevention (CDC) said on Thursday that the benefits of Johnson & Johnson’s COVID-19 vaccine still outweigh the risk of a serious, but rare, neurological disorder following vaccination. The Advisory Committee on Immunization Practices met to discuss the incidence of Guillain-Barré syndrome (GBS) following a…
-
Recent Posts
-
Archives
- May 2025
- April 2025
- July 2023
- June 2023
- May 2023
- April 2023
- March 2023
- February 2023
- January 2023
- December 2022
- November 2022
- October 2022
- September 2022
- August 2022
- July 2022
- June 2022
- May 2022
- April 2022
- March 2022
- February 2022
- January 2022
- December 2021
- November 2021
- October 2021
- September 2021
- August 2021
- July 2021
- June 2021
- May 2021
- April 2021
- March 2021
- February 2021
- January 2021
- December 2020
- September 2013
- July 2013
- March 2013
- January 2013
- December 2012
- November 2012
- December 1
-
Meta